Unresectable Renal Cell Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-05-28
Clinical Trial Update: Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated the combination of talazoparib and axitinib for previously treated advanced renal cell carcinoma.